source : the age
Families involved in two horror mix-ups in which women were implanted with the wrong embryos have received massive secret settlements from Monash IVF.
The fertility giant this week confirmed it had reached agreements with the families involved in embryo bungles at its Brisbane and Clayton clinics, which came to light within four months of each other last year.
Sources familiar with the agreements, but who cannot speak publicly due to the confidential nature of the settlements, have revealed the compensation involved payments of several million dollars to the families.
Families directly impacted included both the birth mother and the biological mother from the Brisbane incident, as well as at least one family involved in the Clayton error.
Monash IVF became aware in February 2025 that an embryo transfer error at its Brisbane facility about a year earlier had resulted in a Queensland woman giving birth to a stranger’s baby.
Investigations into the Brisbane bungle had to be expanded after the company admitted a different woman had been implanted with the wrong embryo during a procedure at its Clayton clinic on June 5.
A Monash IVF spokesperson on Thursday confirmed it had reached agreements with all parties involved in the two embryo mix-ups.
“The company have settled, or agreed to settle, the material claims arising from incidents previously disclosed to the market arising from the Brisbane, Queensland and Clayton, Victoria incidents,” the Monash IVF spokesperson said.
“We deeply regret the events from 2025 and have taken significant steps to strengthen our safety culture and enhance oversight across all sites.
“We have also worked closely with the regulator to ensure our systems meet and, where possible, exceed required standards and community expectations.
“Patients can be confident that we have learned from these events and taken decisive steps to ensure our systems are as rigorous and robust as possible.”
Monash IVF also disclosed in its half-year results report to the Australian Stock Exchange in February that its insurers confirmed indemnity for the claims arising from both incidents, and that the massive compensation payments would not impact shareholders.
“Based on information available at the reporting date, and having regard to insurance coverage in place, the directors do not expect any material exposures to arise in connection with these matters,” Monash IVF told the market.
The embryo errors sent shockwaves through Australia’s fertility industry and forced an urgent overhaul of Australia’s reproductive technology regulation, as well as heartbreak for at least three families directly impacted and distress for thousands of other women undergoing their own procedures.
It also tarnished the reputation of one of the world’s oldest and most respected fertility businesses, with Monash IVF’s share price initially plummeting and its chief executive officer Michael Knapp stepping down within a fortnight of the Clayton error.
The full findings of a Monash IVF-commissioner review by Fiona McLeod, SC, remain secret, however the details that were released found “human error” was at the heart of both embryo mix-ups.
McLeod found that the two incidents were unrelated, different in nature and had occurred years apart. Her review found both cases involved non-standard IVF treatment and circumstances that would not typically arise in the majority of procedures.
While implanting the wrong embryo into a woman in Brisbane was the result of human error alone, McLeod found the Clayton mix-up had resulted from a range of factors, including human error at multiple stages, as well as limitations in the IT system.
The review found that those limitations ultimately made the transfer process more vulnerable to human error.
Start the day with a summary of the day’s most important and interesting stories, analysis and insights. Sign up for our Morning Edition newsletter.
